1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

$Thumbnail for Outpatient Treatment With Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Preliminary Safety Results From a Phase 2 Study$

ABCL - 736

Outpatient Treatment With Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Preliminary Safety Results From a Phase 2 Study

John M. Burke

Poster Presenter: John M. Burke

Video

Thumbnail for Overall and Progression-Free Survival in Patients With Epstein-Barr Virus-Driven Posttransplant Lymphoproliferative Disease (EBV+ PTLD) Following Tabelecleucel Treatment: Results From the Phase 3 ALLELE Trial

CT - 278

Overall and Progression-Free Survival in Patients With Epstein-Barr Virus-Driven Posttransplant Lymphoproliferative Disease (EBV+ PTLD) Following Tabelecleucel Treatment: Results From the Phase 3 ALLELE Trial

Christina Hughes

SOHO 2026 Annual Meeting

Posters by Title

Outpatient Treatment With Glofitamab Plus Gemcitabine and Oxaliplatin (Glofit-GemOx) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Preliminary Safety Results From a Phase 2 Study

Overall and Progression-Free Survival in Patients With Epstein-Barr Virus-Driven Posttransplant Lymphoproliferative Disease (EBV+ PTLD) Following Tabelecleucel Treatment: Results From the Phase 3 ALLELE Trial

Overall Survival and Prognostic Factors in Atypical Chronic Myeloid Leukemia (BCR/ABL-negative): A SEER Population-Based Analysis (2000-2022)

Overall Survival and Prognostic Factors in Lymph Node Accessory Cell Tumors: APopulation-Based Analysis of the SEER Database (2000-2022)

Overall Survival Differs by Treatment Setting in Older Adults With Classical Hodgkin Lymphoma: A National Cancer Database Analysis

Overall Survival With Anti-BCMA Therapies: Indirect Comparison of Belantamab Mafodotin/Bortezomib/Dexamethasone (BVd) vs Teclistamab/Daratumumab (Tec-Dara) in Relapsed/Refractory Multiple Myeloma

Palliative Care Integration in Transfusion-Dependent Myelodysplastic Syndromes: A Real-World Propensity-Matched TriNetX Cohort Study

Patient-Reported Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Advanced-Stage Classic Hodgkin Lymphoma Treated with BrECADD and eBEACOPP: New Data from the HD21 Trial

Patterns of Clinical Presentation and Outcomes in Polycythemia Vera: A Single-Center Study From a Lower-Middle-Income Country (Pakistan)